Your fact-checks will appear here
Teaching hospital in Massachusetts, United States
A review of the provided reporting finds no peer‑reviewed clinical trials of the branded supplement Neurocept itself cited in these sources, while the most concrete trial evidence mentioned relates to...
Available reporting indicates no clear, peer‑reviewed clinical trials specifically testing the branded product “Neurocept.” Commercial marketing and reviews note that ingredients in Neurocept (e.g., B...
The available reporting and the Gates Foundation’s own materials show only fragmentary, indirect evidence in this set of sources that the Bill & Melinda Gates Foundation has funded diabetes research s...
Recent public reporting ties “Neurocept” mainly to consumer-supplement coverage and not to peer‑reviewed clinical trial publications; consumer pieces note it operates under dietary supplement rules an...
Available search results do not mention any product named “Neurodefender,” its clinical testing, or regulatory status. The provided sources discuss neurotherapeutics, clinical trial infrastructure, an...
Available sources do not identify any independent, peer‑reviewed clinical trials that specifically assess a product or drug named “Neurocept.” The search results instead return broad reviews of the Al...
Alzheimer’s treatment reporting mixes robust clinical trials (182 trials of 138 drugs on Jan 1, 2025) with early-stage lab and animal work; disease‑modifying anti‑amyloid antibodies such as lecanemab ...
Available reporting and the websites returned in the search results show no peer‑reviewed clinical trials or registered clinical‑trial entries for a product called "Neurocept"; most coverage is market...
Available sources provided by your search do not mention "Neurocept" clinical trials, leading investigators, or trial locations; reporting instead contains general neurotherapeutics news, conference n...